Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Total Non-Current Liabilities (2022 - 2025)

Historic Total Non-Current Liabilities for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to $1.2 million.

  • PAVmed's Total Non-Current Liabilities changed N/A to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year change of. This contributed to the annual value of $1.8 million for FY2024, which is 8608.64% down from last year.
  • Latest data reveals that PAVmed reported Total Non-Current Liabilities of $1.2 million as of Q3 2025.
  • PAVmed's Total Non-Current Liabilities' 5-year high stood at $57.6 million during Q3 2023, with a 5-year trough of $1.2 million in Q3 2025.
  • For the 4-year period, PAVmed's Total Non-Current Liabilities averaged around $15.0 million, with its median value being $2.1 million (2022).
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first soared by 238524.97% in 2023, then crashed by 8608.64% in 2024.
  • PAVmed's Total Non-Current Liabilities (Quarter) stood at $2.2 million in 2022, then skyrocketed by 492.62% to $12.9 million in 2023, then tumbled by 86.09% to $1.8 million in 2024, then tumbled by 35.72% to $1.2 million in 2025.
  • Its Total Non-Current Liabilities was $1.2 million in Q3 2025, compared to $1.4 million in Q2 2025 and $1.6 million in Q1 2025.